This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

Sponsored by Daiichi Sankyo

About this trial

Last updated 13 years ago

Study ID

866-447

Status

Completed

Type

Interventional

Phase

Phase 4

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 19 years ago

What is this trial about?

A comparison of 2 different combinations of high blood pressure medications to treat hypertension

What are the participation requirements?

Yes

Inclusion Criteria

- Greater than 18 years of age

- Patients with high blood pressure

No

Exclusion Criteria

- Hypertensive encephalopathy, stroke or transient ischemic attack within the past 6 months

- History of myocardial infarction, percutaneous transluminal coronary revascularization, coronary artery bypass graft, and/or unstable angina pectoris within the past 6 months

- Type 1 diabetes mellitus

Locations

Location

Status